STOP-ALF, NCT01548690: Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury |
|
|
| Completed | 2a | 47 | US | Ornithine Phenylacetate, OCR-002 | William Lee, Medical University of South Carolina, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Ocera Therapeutics | Acute Liver Failure, Acute Liver Injury | 02/17 | 02/17 | | |
